16 Clinical Laboratory Predictions for 2024
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Andy Lundin | Nov 16, 2023 | Sexually Transmitted Diseases |
The FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
Read MorePosted by Chris Wolski | Nov 15, 2023 | Cancer |
Timely cancer detection paves the way for interventions that are less toxic, less disruptive, and less costly than treatment in later stages.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostic Analyzers |
BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read MorePosted by Chris Wolski | Nov 14, 2023 | Breast |
PreciseBreast, an AI-powered digital morphology tool, has a fast turnaround time and is cost-effective compared to gene expression tests.
Read More